{"title":"Premorbid sarcopenia and functional outcome after acute stroke: a meta-analysis.","authors":"Yunpan Li, Mei Hong, Hong Shi","doi":"10.6133/apjcn.202309_32(3).0004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Sarcopenia is prevalent in patients with stroke. However, the relationship between sarcopenia and poor functional outcome of patients with acute stroke remains unknown. A systematic review and meta-analysis was performed to evaluate the above association.</p><p><strong>Methods and study design: </strong>Observational studies which evaluated the influence of sarcopenia on functional outcome in patients with acute stroke were retrieved by search the PubMed, Embase, Cochrane Library, and Web of Science databases. A poor functional outcome was defined as modified Rankin scale (mRS) of two or more points during follow-up. Two authors independently collected the data of study characteristics and outcomes. A random-effects model was used to pool the results via incorporating the influence of possible between-study heterogeneity.</p><p><strong>Results: </strong>Nine datasets from seven cohort studies contributed to the meta-analysis. A total of 1774 patients with stroke were included, and 481 (27.1%) of them had sarcopenia. Compared to patients without sarcopenia, those with sarcopenia were associated with a higher risk of poor functional outcome during follow-up duration up to 6 months after stroke onset (odds ratio: 2.42, 95% confidence interval: 1.76 to 3.33, p < 0.001) with mild heterogeneity (I2 = 23%). Subgroup analyses according to study design (prospective versus retrospective), sex of the patient, type of stroke (ischemic or mixed), diagnostic methods for sarcopenia, follow-up duration and cutoff scores for mRS showed consistent results (p for subgroup analyses all > 0.05).</p><p><strong>Conclusions: </strong>Sarcopenia may be associated with poor functional outcome in patients with acute stroke.</p>","PeriodicalId":8486,"journal":{"name":"Asia Pacific journal of clinical nutrition","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090386/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific journal of clinical nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6133/apjcn.202309_32(3).0004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Sarcopenia is prevalent in patients with stroke. However, the relationship between sarcopenia and poor functional outcome of patients with acute stroke remains unknown. A systematic review and meta-analysis was performed to evaluate the above association.
Methods and study design: Observational studies which evaluated the influence of sarcopenia on functional outcome in patients with acute stroke were retrieved by search the PubMed, Embase, Cochrane Library, and Web of Science databases. A poor functional outcome was defined as modified Rankin scale (mRS) of two or more points during follow-up. Two authors independently collected the data of study characteristics and outcomes. A random-effects model was used to pool the results via incorporating the influence of possible between-study heterogeneity.
Results: Nine datasets from seven cohort studies contributed to the meta-analysis. A total of 1774 patients with stroke were included, and 481 (27.1%) of them had sarcopenia. Compared to patients without sarcopenia, those with sarcopenia were associated with a higher risk of poor functional outcome during follow-up duration up to 6 months after stroke onset (odds ratio: 2.42, 95% confidence interval: 1.76 to 3.33, p < 0.001) with mild heterogeneity (I2 = 23%). Subgroup analyses according to study design (prospective versus retrospective), sex of the patient, type of stroke (ischemic or mixed), diagnostic methods for sarcopenia, follow-up duration and cutoff scores for mRS showed consistent results (p for subgroup analyses all > 0.05).
Conclusions: Sarcopenia may be associated with poor functional outcome in patients with acute stroke.
背景和目的:肌萎缩症在脑卒中患者中普遍存在。然而,急性脑卒中患者少肌症与功能不良之间的关系尚不清楚。对上述关联进行了系统回顾和荟萃分析。方法和研究设计:通过检索PubMed、Embase、Cochrane Library和Web of Science数据库,检索评估肌肉减少症对急性卒中患者功能结果影响的观察研究。较差的功能结果被定义为随访期间两个或多个点的改良兰金量表(mRS)。两位作者独立收集了研究特征和结果的数据。使用随机效应模型,通过纳入可能的研究间异质性的影响来汇集结果。结果:来自7项队列研究的9个数据集对荟萃分析做出了贡献。共纳入1774名中风患者,其中481人(27.1%)患有少肌症。与没有少肌症的患者相比,在中风发作后6个月的随访期间,少肌症患者的功能不良风险更高(比值比:2.42,95%置信区间:1.76至3.33,p<0.001),具有轻度异质性(I2=23%)。根据研究设计(前瞻性与回顾性)、患者性别、中风类型(缺血性或混合性)、少肌症的诊断方法、随访时间和mRS的临界分数进行的亚组分析显示出一致的结果(亚组分析的p均>0.05)。
期刊介绍:
The aims of the Asia Pacific Journal of Clinical Nutrition
(APJCN) are to publish high quality clinical nutrition relevant research findings which can build the capacity of
clinical nutritionists in the region and enhance the practice of human nutrition and related disciplines for health
promotion and disease prevention. APJCN will publish
original research reports, reviews, short communications
and case reports. News, book reviews and other items will
also be included. The acceptance criteria for all papers are
the quality and originality of the research and its significance to our readership. Except where otherwise stated,
manuscripts are peer-reviewed by at least two anonymous
reviewers and the Editor. The Editorial Board reserves the
right to refuse any material for publication and advises
that authors should retain copies of submitted manuscripts
and correspondence as material cannot be returned. Final
acceptance or rejection rests with the Editorial Board